Management of Secondary Poor Response to Botulinum Toxin in Cervical Dystonia: A Multicenter Audit

BACKGROUND: Botulinum toxin A (BoNT‐A) is an effective treatment for cervical dystonia. Nevertheless, up to 30% to 40% patients discontinue treatment, often because of poor response. The British Neurotoxin Network (BNN) recently published guidelines on the management of poor response to BoNT‐A in ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Tucker, Harry, Osei‐Poku, Foster, Ashton, Diane, Lally, Rachael, Jesuthasan, Aaron, Latorre, Anna, Bhatia, Kailash P., Alty, Jane E., Kobylecki, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088097/
https://www.ncbi.nlm.nih.gov/pubmed/33977116
http://dx.doi.org/10.1002/mdc3.13181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088097/
https://www.ncbi.nlm.nih.gov/pubmed/33977116
http://dx.doi.org/10.1002/mdc3.13181

Ejemplares similares